The study found that while sitagliptin does not prevent major heart problems like heart attacks or strokes, it may help limit damage to small blood vessels.

Janumet™ (MK-0431A) combines two OADs with complementary mechanisms of action to improve glycemic control, sitagliptin and metformin. The tablet was designed in order to be bioequivalent to ...

Sitagliptin, an oral glucose-lowering agent, has been found to produce cardiovascular protection possibly via anti-inflammatory and anti-atherosclerotic activities of glucagon-like peptide-1 receptor ...

Diabetes type 2 arises slowly after years of prediabetes. The diabetes drug sitagliptin improves many of the problems that mark prediabetes, including high levels of blood sugar after meals and ...

Results presented at the 77th Scientific Sessions of the American Diabetes Association are for combinations with ertugliflozin, an investigational SGLT2 inhibitor before FDA. Ertugliflozin, the ...

Objective: To evaluate attainment of diabetes-related quality measures with canagliflozin, a sodium glucose cotransporter 2 inhibitor, versus sitagliptin in patients with type 2 diabetes mellitus ...

Silver Spring, MD -The US Food and Drug Administration (FDA) announced that it is revising prescribing information for diabetes drugs sitagliptin (Januvia, Merck) and sitagliptin/metformin (Janumet, ...

Sitagliptin and glipizide monotherapy is safe and effective in patients with type 2 diabetes and end-stage renal disease (ESRD) requiring dialysis, researchers reported online ahead of print in the ...

Bristol-Myers Squibb and AstraZeneca announced results from a Phase 3 clinical study that showed the investigational compound dapagliflozin demonstrated significant reductions in HbA1C compared with ...

Get detailed information on Simvastatin and Sitagliptin, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated ...

Please provide your email address to receive an email when new articles are posted on . Among adults initiating type 2 diabetes therapy, dapagliflozin and sitagliptin were associated with similar ...

Please provide your email address to receive an email when new articles are posted on . Liraglutide appears to be more effective in reducing HbA1c, fasting plasma glucose and weight compared with ...